The American Journal of Managed Care1 年
Leveraging GOLD Guidance and Value-Based Strategies in the Management of COPD
Whereas the GOLD 2022 report noted the efficacy of LABA+ICS in patients with moderate to very severe COPD and exacerbations, the GOLD 2023 and 2024 reports underscore, “Use of LABA+ICS in COPD ...